Fairmount Funds Management LLC Diversified Active

Location: West Conshohocken, PA

CIK: 0001802528 · Show all filings

Period: Q3 2025 (← Previous) (Next →)

Filing Date: Nov 14, 2025

Total Value: $1.111B (100.0% shares, 0.0% debt)

Holdings (17)

DNTH DIANTHUS THERAPEUTICS INC 11.7%
Value $130M Shares 3,307,191 Est. Cost $17.22 Unrealized +48.4%
COGT COGENT BIOSCIENCES INC 11.6%
Value $129M Shares 9,003,418 Est. Cost $9.55 Unrealized +24.0%
AXSM AXSOME THERAPEUTICS INC 8.9%
Value $99M Shares 815,176 Est. Cost $49.79 Unrealized +126.3%
APGE APOGEE THERAPEUTICS INC 7.3%
Value $81.39M Shares 2,048,647 Est. Cost $22.03 Unrealized +73.3%
ELVN ENLIVEN THERAPEUTICS INC 6.8%
Value $75.97M Shares 3,711,444 Est. Cost $18.70 Unrealized +7.8%
VRDN VIRIDIAN THERAPEUTICS INC 6.7%
Value $74.66M Shares 3,459,913 Est. Cost $16.55 Unrealized +9.0%
ORKA ORUKA THERAPEUTICS INC 6.4%
Value $71.25M Shares 3,705,262 Est. Cost $32.55 Unrealized -54.5%
KNSA KINIKSA PHARMACEUTICALS INTL 6.2%
Value $68.84M Shares 1,772,839 Est. Cost $21.28 Unrealized +52.7%
SRRK SCHOLAR ROCK HLDG CORP 6.1%
Value $67.93M Shares 1,824,031 Est. Cost $32.27 Unrealized +8.4%
SYRE SPYRE THERAPEUTICS INC 6.1%
Value $67.34M Shares 4,018,101 Est. Cost $31.80 Unrealized -48.7%
NUVL NUVALENT INC 5.7%
Value $62.92M Shares 727,563 Est. Cost $22.67 Unrealized +248.8%
ABVX ABIVAX SA 5.4%
Value $60.57M Shares 713,434 Est. Cost $84.90 Unrealized
ZBIO ZENAS BIOPHARMA INC 3.8%
Value $42.02M Shares 1,892,806 Est. Cost $17.98 Unrealized -9.5%
JBIO JADE BIOSCIENCES INC 2.5%
Value $27.79M Shares 3,220,368 Est. Cost $33.31 Unrealized -75.5%
ASTRIA THERAPEUTICS INC 2.3%
Value $25.87M Shares 3,554,129 Est. Cost $9.99 Unrealized
CBIO CRESCENT BIOPHARMA INC. 1.5%
Value $16.5M Shares 1,387,866 Est. Cost $21.15 Unrealized -37.3%
IKT INHIBIKASE THERAPEUTICS INC 0.9%
Value $9.922M Shares 6,125,000 Est. Cost $2.49 Unrealized -30.6%